Unravelling the molecular mechanisms causal to type 2 diabetes across global populations and disease-relevant tissues

Read full text
Authors: Ozvan Bocher, Ana Luiza Arruda, Satoshi Yoshiji, Chi Zhao, Alicia Huerta-Chagoya, Chen-Yang Su, Xianyong Yin, Davis Cammann, Henry J. Taylor, Jingchun Chen, Ken Suzuki, Ravi Mandla
+12 more Ta-Yu Yang, Fumihiko Matsuda, Josep M. Mercader, Jason A. Flannick, James B. Meigs, Alexis C. Wood, Marijana Vujković, Benjamin F. Voight, Cassandra Nichole Spracklen, Jerome I. Rotter, Andrew P. Morris, Eleftheria Zeggini
Cited by: 1
References: 76

Abstract

Type 2 diabetes (T2D) is a prevalent disease arising from complex molecular mechanisms. Here we leverage T2D genetic associations to identify causal molecular mechanisms in an ancestry-aware and tissue-aware manner. Using two-sample Mendelian randomization corroborated by colocalization across four global ancestries, we analyse 20,307 gene and 1,630 protein expression levels using blood-derived cis-quantitative trait loci (QTLs). We detect causal effects of genetically predicted levels of 335 genes and 46 proteins on T2D risk, with 16.4% and 50% replication in independent cohorts, respectively. Using gene expression cis-QTLs derived from seven T2D-relevant tissues, we identify causal links between the expression of 676 genes and T2D risk, refining known associations such as BAK1 and describing additional ones like CPXM1. Causal effects are mostly shared across ancestries but are highly heterogeneous across tissues. Our findings provide insights into cross-ancestry and tissue-informed multi-omics causal inference approaches and demonstrate their power in uncovering molecular processes driving T2D.

Fields of Study & Subjects

Genetic Associations and Epidemiology Genetic Mapping and Diversity in Plants and Animals Bioinformatics and Genomic Networks

Publication details

Journal / source
Nature Metabolism
Publisher
Springer Science and Business Media LLC
Volume
8
Issue
2
Pages
506–520
Publication date
27 January 2026
Language
EN